Cantor Fitzgerald initiated coverage of CVS Health with an Overweight rating and $87 price target. The analyst says investors are underestimating the "power of the flywheel CVS is piecing together." The firm sees the company’s 2025 earnings per share guidance as conservative, and estimates a bull scenario could generate $10.50-11.00 versus the guide of $10.00.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CVS:
- CVS Health division enters collaboration with Catholic Health
- CVS Health price target lowered to $111 from $118 at TD Cowen
- ‘I don’t see a big recession’: BlackRock boss Larry Fink dismisses concerns of an economic downturn this year — here are 3 top stocks to bet on it
- Ex-Dividend Date Nearing for These 10 Stocks – Week of April 17, 2023
- Grab 2 Analyst Favorite Stocks as They Go Ex-Dividend Next Week
